Maintenance of stemness by rho kinase inhibitor thiazovivin in bovine embryonic pluripotent stem cells

• In: Posters B- Biotechnology (Vaccine)
• At: PSWC, Melbourne (Australia) (2014)
• Type: Poster
• Poster code: PB-001
• By: ROH, Sangho (Seoul National University, School of Dentistry, Seoul, South-Korea)
• Co-author(s): Park, S. (Seoul National University, Seoul, South-Korea)
  Kim, D. (Seoul National University, Seoul, South-Korea)
  Kim (ET Biotech, Daegu, South-Korea)
  Jung (ET Biotech, Daegu, South-Korea)
  
• Abstract:

  Bovine embryonic stem (ES) cells can be a valuable cell source in the field of agriculture and biomedicine. Although many attempts have been reported, the complete bovine ES cells are rarely reported yet. Previous studies show that Thiazovivin (Tzv), a Rho-associated kinase inhibitor (ROCKi), improves the survival and self-renewal of human ES

  ..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login